Related Experiment Videos
Short-acting beta-adrenergic blockade and the fetus. A case report
G J Gilson1, K J Knieriem, J F Smith
1Department of Obstetrics and Gynecology, University of New Mexico Hospital, Albuquerque 87131.
The Journal of Reproductive Medicine
|March 1, 1992
Abstract:
An infant was born to a woman who received intravenous esmolol for intrapartum supraventricular tachyarrhythmia. Despite the very short acting and cardio-selective beta-1 adrenergic blockade induced by that agent, neonatal effects can occur up to 48 hours after delivery.